Risk factors of recurrence of macular oedema associated with branch retinal vein occlusion after intravitreal bevacizumab injection
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Yoo, Jun Ho | - |
dc.contributor.author | Ahn, Jaemoon | - |
dc.contributor.author | Oh, Jaeryung | - |
dc.contributor.author | Cha, Jaehyung | - |
dc.contributor.author | Kim, Seong-Woo | - |
dc.date.accessioned | 2021-09-03T00:44:40Z | - |
dc.date.available | 2021-09-03T00:44:40Z | - |
dc.date.created | 2021-06-19 | - |
dc.date.issued | 2017-10 | - |
dc.identifier.issn | 0007-1161 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/82024 | - |
dc.description.abstract | Background/aims To identify risk factors of recurrence of macular oedema in branch retinal vein occlusion (BRVO) after intravitreal bevacizumab (IVB) injection. Methods The records of 63 patients who underwent IVB injection for macular oedema secondary to BRVO with at least 6 months of follow-up were reviewed. Patients were evaluated at baseline with fluorescein angiography (FA), optical coherence tomography (OCT) and ultra-wide-field fundus photography (WFP). During follow-up, OCT and WFP were repeated. The area of retinal haemorrhage, central retinal thickness (CRT), area (mm(2)) of capillary non-perfusion within the 1 mm (NPA1), 1-3 mm and 6 mm zones of the ETDRS circle, foveal capillary filling time, degree (degrees) of foveal capillary network destruction and FA pattern were analysed. Results Macular oedema recurred in 41 of 63 (65.1%) eyes after initial IVB injection. A binary logistic regression model showed that NPA1 (OR=434.97; 95% CI=5.52 to 34262.12, p=0.006) and initial CRT (OR=1.004; 95% CI=1.000 to 1.008, p=0.015) were significantly associated with the recurrence of macular oedema. Receiver operating characteristic curve analysis identified an NPA1 of 0.36 mm(2) (AUC: 0.735, sensitivity: 70.7%; specificity: 63.6%) and an initial CRT of 570 mm (AUC: 0.745, sensitivity: 63.4%; specificity: 77.3%) as cut-off values for predicting recurrence of macular oedema. Conclusions Patients with BRVO with non-perfusion of more than half of the 1 mm zone of the ETDRS circle or with an initial CRT >570 mu m should be closely monitored for macular oedema recurrence within 6 months of IVB injection. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | BMJ PUBLISHING GROUP | - |
dc.subject | ENDOTHELIAL GROWTH-FACTOR | - |
dc.subject | GRID PHOTOCOAGULATION | - |
dc.subject | SECONDARY | - |
dc.subject | INTERLEUKIN-6 | - |
dc.subject | NONPERFUSION | - |
dc.subject | RANIBIZUMAB | - |
dc.subject | THERAPY | - |
dc.subject | EYES | - |
dc.title | Risk factors of recurrence of macular oedema associated with branch retinal vein occlusion after intravitreal bevacizumab injection | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Kim, Seong-Woo | - |
dc.identifier.doi | 10.1136/bjophthalmol-2016-309749 | - |
dc.identifier.scopusid | 2-s2.0-85030264449 | - |
dc.identifier.wosid | 000411681700008 | - |
dc.identifier.bibliographicCitation | BRITISH JOURNAL OF OPHTHALMOLOGY, v.101, no.10, pp.1334 - 1339 | - |
dc.relation.isPartOf | BRITISH JOURNAL OF OPHTHALMOLOGY | - |
dc.citation.title | BRITISH JOURNAL OF OPHTHALMOLOGY | - |
dc.citation.volume | 101 | - |
dc.citation.number | 10 | - |
dc.citation.startPage | 1334 | - |
dc.citation.endPage | 1339 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Ophthalmology | - |
dc.relation.journalWebOfScienceCategory | Ophthalmology | - |
dc.subject.keywordPlus | ENDOTHELIAL GROWTH-FACTOR | - |
dc.subject.keywordPlus | GRID PHOTOCOAGULATION | - |
dc.subject.keywordPlus | SECONDARY | - |
dc.subject.keywordPlus | INTERLEUKIN-6 | - |
dc.subject.keywordPlus | NONPERFUSION | - |
dc.subject.keywordPlus | RANIBIZUMAB | - |
dc.subject.keywordPlus | THERAPY | - |
dc.subject.keywordPlus | EYES | - |
dc.subject.keywordAuthor | Macula | - |
dc.subject.keywordAuthor | Retina | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.